Symposium 2026 is coming with renewed energy and vision. Join us virtually for four dynamic days to experience a new era of optical genome mapping (OGM), featuring 30+ global experts sharing pioneering data that’s driving the field of OGM forward.
Engage with OGM experts from all over the world driving discovery in hematologic malignancies, solid tumors, constitutional genetic disorders, cell and gene therapy, and beyond through live presentations, Q&A sessions, and roundtables. Plus, submit a poster to be entered into our poster competition!
From leukemias, to lymphomas and myelomas, see how cytogenetic laboratories and key opinion leader (KOL) networks in different countries have implemented OGM across multiple clinical research applications and how the workflow performs in comparison to traditional cytogenetic and molecular methods. Hear from experts building the framework around OGM implementation and the added value in precision, sensitivity and understanding of novel, driver structural variants in heme malignancy applications.
Discover how OGM performs for the most challenging Heme malignancy indications, such as multiple myeloma and lymphomas, and see the latest OGM data and results from multiple groundbreaking studies. See how experts are utilizing Bionano’s workflow to unveil pathogenic & driver structural variants in solid tumors such as breast & ovarian cancers and soft tissue tumors. Also, discover how OGM is playing a key role as a quality control (QC) tool for assessing the genome integrity of various cell bioprocessing applications.
Become inspired by genetic disease research, including the rare and unresolved, where OGM is key to the discovery of relevant variants after multiple other traditional methods had failed to provide answers. Receive updates from the OGM global base of users from Japan, India, Italy, France, Poland, Turkey, and US, where OGM was instrumental in providing answers for the analysis of pre-natal, post-natal samples, and reproductive disorders and beyond.
Learn about Bionano products, including Ionic, Saphyr, Stratys, and VIA, directly from our customers. Key opinion leaders from US, Canada, and Netherlands will share their experience and data from isolating FFPE DNA from Ionic (isotachophoresis) workflow for downstream NGS applications, novel, semi-automated ultra-high molecular DNA isolation by the Ionic methos for OGM, customer experience using the high throughput Stratys system and how customers are using the VIA software solutions for heme malignancies and constitutional genetic disease applications. Don’t miss the chance to discover an interesting tool (OMKAR) to create a digital karyotype of OGM data of rearranged chromosomes!
Attendance at all sessions of interest is strongly encouraged! Presentations will be available on demand on the Bionano YouTube page after Symposium 2026 concludes.
Bionano solutions are for Research Use Only. Not for use in diagnostic procedures.